跳至主要内容
临床试验/NCT07278401
NCT07278401招募中不适用

Community Pharmacies as Social Determinant of Health Navigators

State University of New York at Buffalo10 个研究点 分布在 1 个国家目标入组 1,600 人开始时间: 2025年10月1日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
1,600
试验地点
10
主要终点
Effectiveness Outcomes

研究概览

简要总结

Type 1 hybrid effectiveness-implementation study using a quasi-experimental, difference-in-difference (DID) design to deliver a comprehensive social needs screening and navigation program by integrating Community Health Workers (CHWs) into community pharmacies across under-resourced areas in Western New York (WNY).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult subjects ≥ 18 years
  • English speaking
  • Presenting to one of the participating pharmacies. For the pharmacies to be included, they must be enrolled within the Community Pharmacy Enhanced Services Network - NY (CPESN-NY) or associated with Tops Pharmacies. The pharmacies must have the ability to collaborate with Healthelink and referring partners (e.g., Wellconnected) and the staffing capacity to have a SDoH screening program with Community Health Worker Training. The pharmacies' physical address must be located within Erie County

排除标准

  • Subjects ≤ 18 years

结局指标

主要结局

Effectiveness Outcomes

时间窗: 12 months

Primary effectiveness outcomes in composite healthcare utilization including hospital admissions and ED visits at 12 months, and we hypothesize that utilization will be reduced in subjects who receive a pharmacy social needs intervention.

次要结局

  • Cost Analysis(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

David Matthew Jacobs

Associate Professor

State University of New York at Buffalo

研究点 (10)

Loading locations...

相似试验

进行中(未招募)
不适用
A community pharmacy based investigation in the self-medication areaEfficacy and safety of Sinutab® [Paracetamol (500mg) and Pseudoephedrine (30mg)] on subjects with nasal congestion accompanied by headache in the setting of a common coldThe medical rationale = to investigate this combination drug in the symptomatic relief of common cold with nasal symptoms. The reduction of symptom severity may allow subjects receiving active medication to return to work or school earlier than those receiving placebo. To study the drug in it’s ‘natural environment’, community pharmacists will function as local investigators. They will include subjects with early (= 48 hours) cold symptoms of blocked nose with headache.
EUCTR2006-000058-35-BEPfizer Consumer Healthcare Comm. VA/SCA
进行中(未招募)
不适用
A community pharmacy based investigation in the self-medication areaEfficacy and safety of Sinutab® (Paracetamol (500mg)/Pseudoephedrine (30mg)) on subjects with nasal congestion accompanied by headache and/or fever in the setting of a common coldMedical rationale= Investigation of combination drug Sinutab in symptomatic relief of common cold with nasal symptoms. Community pharmacists are considered as local investigators including subjects with early (= 48 hours) cold symptoms of blocked nose with headache and/or fever.
EUCTR2004-001637-41-BEPfizer Consumer Healthcare cva/sca
招募中
不适用
Increasing Community Pharmacy Involvement in the Prevention of Cardiovascular Disease Project
ACTRN12609000705280Monash450
尚未招募
Unknown
Evaluation of efficacy of the community pharmacy intervention to optimize serum potassium levels in patients with chronic kidney diseasechronic kidney disease
JPRN-UMIN000049814ational Hospital Organization Mie Chuo Medical Center40
尚未招募
不适用
PrEP & Soccer: A Program for Pharmacy Chains to Increase PrEP Awareness and Access Among MenLatino Men Who Have Sex With Men
NCT07263048University of Miami800